{"id":5183,"date":"2022-09-22T00:00:00","date_gmt":"2022-10-14T16:15:26","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-1-exacerbation-dans-lannee-precedente\/"},"modified":"2023-05-02T08:30:04","modified_gmt":"2023-05-02T12:30:04","slug":"expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente","status":"publish","type":"eb_course","link":"http:\/\/www.mdbriefcase.com\/fr\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/","title":{"rendered":"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente"},"content":{"rendered":"<p>La MPOC est l\u2019une des affections les plus courantes observ\u00e9es en soins primaires. Compte tenu des nombreuses options th\u00e9rapeutiques qui peuvent \u00eatre envisag\u00e9es pour ces patients, il est important que les cliniciens de soins primaires connaissent les donn\u00e9es probantes actuelles pour guider leur choix de traitement. Cette s\u00e9rie passera en revue les donn\u00e9es probantes actuelles, les comparera aux lignes directrices actuelles et les appliquera aux cas courants rencontr\u00e9s dans la pratique clinique.\n<\/p>\n<hr>\n<p>Ce programme de formation a fait l\u2019objet d\u2019une bourse \u00e0 vis\u00e9e \u00e9ducative ou d\u2019un soutien en nature de la part de GSK.<\/p>","protected":false},"featured_media":440803,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-5183","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-\u2265-1-exacerbation-dans-lannee-precedente\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"La MPOC est l\u2019une des affections les plus courantes observ\u00e9es en soins primaires. Compte tenu des nombreuses options th\u00e9rapeutiques qui peuvent \u00eatre envisag\u00e9es pour ces patients, il est important que les cliniciens de soins primaires connaissent les donn\u00e9es probantes actuelles pour guider leur choix de traitement. Cette s\u00e9rie passera en revue les donn\u00e9es probantes actuelles, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-\u2265-1-exacerbation-dans-lannee-precedente\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T12:30:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/\",\"name\":\"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg\",\"datePublished\":\"2022-10-14T16:15:26+00:00\",\"dateModified\":\"2023-05-02T12:30:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-\u2265-1-exacerbation-dans-lannee-precedente\/","og_locale":"fr_CA","og_type":"article","og_title":"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente - MDBriefCase","og_description":"La MPOC est l\u2019une des affections les plus courantes observ\u00e9es en soins primaires. Compte tenu des nombreuses options th\u00e9rapeutiques qui peuvent \u00eatre envisag\u00e9es pour ces patients, il est important que les cliniciens de soins primaires connaissent les donn\u00e9es probantes actuelles pour guider leur choix de traitement. Cette s\u00e9rie passera en revue les donn\u00e9es probantes actuelles, [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-\u2265-1-exacerbation-dans-lannee-precedente\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T12:30:04+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/","url":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/","name":"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg","datePublished":"2022-10-14T16:15:26+00:00","dateModified":"2023-05-02T12:30:04+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/09\/COPD-M3-LP-127625237-44.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-en-bref-3-la-bitherapie-par-rapport-a-la-tritherapie-chez-les-patients-ayant-un-antecedent-de-%e2%89%a5-1-exacerbation-dans-lannee-precedente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Expert en Bref 3 : La bith\u00e9rapie par rapport \u00e0 la trith\u00e9rapie chez les patients ayant un ant\u00e9c\u00e9dent de \u2265 1\u00a0exacerbation dans l\u2019ann\u00e9e pr\u00e9c\u00e9dente"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=5183"}],"version-history":[{"count":0,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5183\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/440803"}],"wp:attachment":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=5183"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=5183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}